Fulcrum Therapeutics, Inc. (FULC) Insider Trading -- Recent Executive & Director Transactions

8 insiders reported 19 Form 4 transactions for Fulcrum Therapeutics, Inc. (FULC) over the past 18 months (most recent 2026-06-30). Recent activity: Ezekowitz Alan (Director) Sell 18,000 shares, Gould Robert J (Director) Sell 15,000 shares, Gould Robert J (Director) Sell 15,000 shares, Gould Robert J (Director) Sell 15,000 shares, Oltmans Curtis Gale (Chief Legal Officer) Sell 3,452 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-06-30Ezekowitz AlanDirectorSell18,000$65,614
2026-02-04Gould Robert JDirectorSell15,000$163,050
2026-02-04Gould Robert JDirectorSell15,000$160,800
2026-01-06Gould Robert JDirectorSell15,000$178,050
2025-12-17Oltmans Curtis GaleChief Legal OfficerSell3,452$44,600
2025-12-10Shah Rajeev M.InsiderSell1.4M$18.4M
2025-12-10RA CAPITAL MANAGEMENT, L.P.InsiderSell1.4M$18.4M
2025-12-10Kolchinsky PeterInsiderSell1.4M$18.4M
2025-12-10RA Capital Healthcare Fund LPInsiderSell1.4M$18.4M
2025-12-10RA Capital Healthcare Fund LPInsiderSell2.7M$38.6M
2025-12-10RA CAPITAL MANAGEMENT, L.P.InsiderSell2.7M$38.6M
2025-12-10Kolchinsky PeterInsiderSell2.7M$38.6M
2025-12-10Shah Rajeev M.InsiderSell2.7M$38.6M
2025-12-10RA Capital Healthcare Fund LPInsiderSell91,722$1.4M
2025-12-10RA CAPITAL MANAGEMENT, L.P.InsiderSell91,722$1.4M
2025-12-10Kolchinsky PeterInsiderSell91,722$1.4M
2025-12-10Shah Rajeev M.InsiderSell91,722$1.4M
2025-11-21Gould Robert JDirectorSell15,000$165,450
2025-05-09Tourangeau GregPrincipal Accounting OfficerSell498$2,520

Source: SEC Form 4 filings · as of 2026-06-30